Today: 10 April 2026
Subscribe
Browse Category

NASDAQ:SMCI 8 August 2025 - 24 October 2025

Supermicro Stock Plunges 8% After Revenue Forecast Cut – Is the AI Server Gold Rush Over?

Supermicro Stock Plunges 8% After Revenue Forecast Cut – Is the AI Server Gold Rush Over?

Super Micro Computer shares dropped about 8% on Oct. 23 after the company cut its Q1 FY2026 revenue forecast to $5 billion, down from $6–7 billion. Management cited delayed AI server orders but reaffirmed its full-year revenue target of at least $33 billion. SMCI stock remains up roughly 60–70% in 2025. Analysts remain split on the outlook ahead of Nov. 4 earnings.
24 October 2025
··
AI Stock Boom or Bubble? Tech Rally Soars as Experts Warn of Risk

Supermicro Stock Plunges 8% as AI Server Boom Hits a Snag – What’s Next for SMCI?

Super Micro Computer shares fell about 8% to the high $40s on October 23 after the company cut its quarterly revenue forecast by $1–2 billion, citing delayed AI server orders. Management maintained its full-year sales outlook of $33 billion and said over $12 billion in deals are now expected next quarter. SMCI stock remains up more than 70% this year. Goldman Sachs kept a Sell rating with a price target in the high $20s.
23 October 2025
·
AI Stock Boom or Bubble? Tech Rally Soars as Experts Warn of Risk

AI Stock Boom or Bubble? Tech Rally Soars as Experts Warn of Risk

Nvidia, Microsoft, Apple, Alphabet, and Amazon now account for nearly 30% of the S&P 500’s value, the highest since 1964. The S&P 500 and Nasdaq hit record highs in October, driven by AI stocks like Nvidia and Palantir, which is up about 300% this year. Analysts warn valuations are stretched, with Palantir trading at over 100× sales and Nvidia at over 300× earnings. Some experts fear an AI-driven bust could erase trillions in U.S. wealth.
23 October 2025
·········
Supermicro (SMCI) Stock Soars: Hedge Funds Snatch Up Shares as AI Data Center Boom Accelerates

Supermicro (SMCI) Stock Soars: Hedge Funds Snatch Up Shares as AI Data Center Boom Accelerates

CEO Charles Liang sold 200,000 SMCI shares (~$12M) in late July, while other executives disposed of nearly 290,000 more, bringing insider sales to about 490,000 shares (~$28M) last quarter. SMCI missed Q2 earnings estimates and cut its full-year revenue target to at least $33B. Shares surged from ~$48 in late September to $52.18 on Oct. 20. Wall Street consensus remains “Hold,” with average price targets in the mid-$40s.
20 October 2025
····
SMCI Stock Soars After Rebound: What Investors Need to Know in October 2025

Supermicro Surges in the AI Server Boom: Latest Stock Moves, Breakneck Growth, and What’s Next

Supermicro shares surged from $48 to the mid-$50s in early October 2025, boosted by a major AMD-OpenAI deal and strong AI server demand. Fiscal 2025 revenue hit $22 billion, but Q4 sales missed estimates and margins fell. Management cut its FY2026 revenue outlook to at least $33 billion. Analyst sentiment is mixed, with price targets ranging from $27 to $60 amid rising competition and cost pressures.
7 October 2025
·
Super Micro Computer (SUPX) 2025: Can the AI‑Server Pure‑Play Keep Its Edge?

Super Micro Computer (SUPX) 2025: Can the AI‑Server Pure‑Play Keep Its Edge?

Super Micro Computer reported fiscal 2025 net sales of $22 billion, up sharply from two years ago, but fourth-quarter revenue of $5.8 billion missed estimates and net income fell to $195 million. Management lowered fiscal 2026 sales guidance to at least $33 billion, down from $40 billion. Shares dropped 15.5% after the Q4 miss and guidance cut. Analysts remain cautious amid margin pressure and volatile stock performance.
4 October 2025
··
Tech World Rocked by 8 Non‑AI Surprises This Week

Tech World Rocked by 8 Non‑AI Surprises This Week

Apple is developing a home companion robot with a 7-inch movable display and advanced Siri, targeting a 2027 launch. The FDA approved Insmed's Brinsupri as the first treatment for non-cystic fibrosis bronchiectasis, priced at $88,000 per year. ULA's Vulcan rocket completed its first operational flight, carrying Space Force payloads from Cape Canaveral. Amazon expanded Prime same-day grocery delivery to over 1,000 U.S. cities.
14 August 2025
···········
AI Stocks Frenzy: Mega Deals, GPT-5 Hype and Bubble Warnings Fuel Aug 9–10 Market Buzz

AI Stocks Frenzy: Mega Deals, GPT-5 Hype and Bubble Warnings Fuel Aug 9–10 Market Buzz

AMD’s Q2 data-center chip sales rose 14% to $3.2 billion but missed estimates, while SMCI shares plunged 18% after cutting guidance, erasing over $6 billion in value. Nvidia stock jumped 73% and later hit record highs alongside Broadcom as the AI-chip rally resumed. The U.S. began licensing Nvidia’s H20 AI GPUs to China, drawing criticism from Chinese state media. Meta secured $29 billion in financing for new AI data centers.
10 August 2025
··············
AI Stocks Frenzy: GPT-5 Hype, Record Highs & Billion-Dollar Bets Fuel Aug 8–9 Market Surge

AI Stocks Frenzy: GPT-5 Hype, Record Highs & Billion-Dollar Bets Fuel Aug 8–9 Market Surge

The U.S. began licensing Nvidia to export H20 AI chips to China on Aug. 7, reversing a ban. OpenAI launched GPT-5 the same day, citing 700 million ChatGPT users. AMD shares dropped 5.1% and SMCI plunged 18.2% after weak Q2 data-center results. The Nasdaq Composite notched its 18th record high of 2025 on Aug. 8, led by AI and tech stocks.
9 August 2025
···········
AI Stocks Frenzy: Record Highs, GPT‑5 Launch, Soaring Tech Giants and SoftBank’s Big AI Payday (Aug 7–8, 2025)

AI Stocks Frenzy: Record Highs, GPT‑5 Launch, Soaring Tech Giants and SoftBank’s Big AI Payday (Aug 7–8, 2025)

The Nasdaq Composite hit a record by Aug. 7, 2025, as chipmakers and AI stocks surged. AMD fell 5% and SMCI dropped over 18% after disappointing data-center results, while Palantir jumped 9% after raising its revenue forecast. Meta secured $29 billion for AI data centers, and SoftBank soared 13% to a record high in Tokyo after strong earnings and a $30 billion OpenAI stake. China’s robotics stocks rallied ahead of the World Robotics Conference.
8 August 2025
············
1 … 4 5 6

Stock Market Today

  • Vera Therapeutics (VERA) Share Price Surges 87% in One Year: Is It Still Undervalued?
    April 10, 2026, 7:16 AM EDT. Vera Therapeutics (VERA) shares have jumped 87.7% over the past year, despite a 15.8% decline year-to-date. The biotech's latest share price stands at $40.93, showing modest recent gains. Analysts use a discounted cash flow (DCF) model projecting positive free cash flows by 2030 to estimate an intrinsic value of roughly $436.15 per share, indicating the stock may be undervalued by over 90%. The DCF model considers future cash flows discounted to today's value, reflecting the firm's growth potential despite current losses. Vera's price-to-book ratio sits at 4.83, above the biotech sector average, suggesting investors expect significant growth prospects amid some risk. This valuation mix presents a nuanced picture of Vera's appeal in a volatile sector.

Latest article

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

10 April 2026
London’s FTSE 100 rose 0.38% to 10,644.28 late Friday morning as investors awaited U.S.-Iran talks in Pakistan. Brent crude climbed 1% to $96.83 a barrel, while sterling eased but was on track for its biggest weekly gain since January. The FTSE 250 gained 0.79%. Britain’s 10-year gilt yield stood at 4.807%.
US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

10 April 2026
Dow e-minis slipped 0.15% before Friday’s open, with S&P 500 and Nasdaq 100 futures each down 0.08% as traders awaited March CPI data and watched U.S.-Iran tensions. Economists expect headline CPI to rise 0.9% for March and 3.3% year-on-year. Weekly jobless claims increased to 219,000. Brent crude traded near $97 a barrel, while shipping through the Strait of Hormuz remained well below normal.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 7:26 AM EDT Vera Therapeutics (VERA) Share Price Surges 87% in One Year: Is It Still Undervalued? April 10, 2026, 7:16 AM EDT. Vera Therapeutics (VERA) shares have jumped 87.7% over the past year, despite a 15.8% decline year-to-date. The biotech's latest share price stands at $40.93, showing modest recent gains. Analysts use a discounted cash flow (DCF) model projecting positive free cash flows by 2030 to estimate an intrinsic value of roughly $436.15 per share, indicating the stock may be undervalued by over 90%. The DCF model
MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
Go toTop